Inter-Institutional Agreement with the University of Chicago

Name of License: 
Inter-Institutional Agreement with the University of Chicago
By the: 
U.S. Army Medical Research & Development Command - Medical Technology Transfer Office (MTT)
Summary 

In accordance with applicable laws and regulations, announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license.

Tech Name: 
Compounds for Treating and Detecting Apicomplexan Parasitic Diseases
Action: 
Intent
Dates: 
13 October 2020
Address: 
Commander, U.S. Army Medical Research and Development Command, ATTN: Director, Office of Research and Technology Applications, 1520 Freedman Drive, Suite 227, Fort Detrick, MD 21702-5012.
For further information contact 

Mr. Paul Michaels, Office of Research & Technology Applications, (301) 619-4145. For patent issues, Ms. Leigh Callander, Supervisory Patent Attorney, (301) 619-7808.

Supplementary information 

In accordance with 35 U.S.C. 209 (e) and 37 CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license to United States Patent Application 16/063,877 with an effective filing date of December 21, 2015, entitled “Compounds and Methods for Treating, Detecting, and Identifying Compounds to Treat Apicomplexan Parasitic Diseases” to the University of Chicago having its principal place of business at 1542 E. 53rd St, 2nd Floor, Chicago, IL 60615.
Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Director, Office of Research and Technology Applications (see ADDRESSES).

Correction: